title: GDPs and AGEs: local and systemic effects in PD patients.
authors.affiliation: Gambro Corporate Research, Lund, Sweden. ingrid.ledebo@gambro.com
authors.forename: Ingrid
authors.initials: I
authors.lastname: Ledebo
authors.forename: Anders
authors.initials: A
authors.lastname: Wieslander
authors.forename: Reinhold
authors.initials: R
authors.lastname: Deppisch
mesh_terms: D002478:Cells, Cultured; D015314:Dialysis Solutions / Q000009:adverse effects* / Q000493:pharmacokinetics* / Q000494:pharmacology; D004847:Epithelial Cells / Q000187:drug effects; D005260:Female; D005500:Follow-Up Studies; D005947:Glucose / Q000378:metabolism*; D017127:Glycation End Products, Advanced / Q000378:metabolism*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy; D008297:Male; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects* / Q000379:methods; D010537:Peritoneum / Q000166:cytology / Q000187:drug effects; D018570:Risk Assessment
chemical_list: D015314:Dialysis Solutions; D017127:Glycation End Products, Advanced; D005947:Glucose